SCHEMBL6060019

SCHEMBL6060019

CCCCc1ccc2cc(-c3ccc(-c4ccc(C(F)(F)F)cc4)c(F)c3)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 3/20 0.44
APP P05067 2/20 0.43
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
RORC P51449 3/20 0.39
RARA P10276 1/20 0.39
RARG P13631 1/20 0.39
KIF11 P52732 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
MAOB P27338 1/20 0.38
PSMB5 P28074 1/20 0.38
MPL P40238 2/20 0.38
RORA P35398 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
GRM2 Q14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6060003 0.96 RARB (0.49) RARBAPPAKR1C3AKR1C2RORC
SCHEMBL6060353 0.95 RARB (0.51) RARBAPPAKR1C3AKR1C2RORC
SCHEMBL6060536 0.95 RARB (0.51) RARBAPPAKR1C3AKR1C2RORC
SCHEMBL6059861 0.92 APP (0.45) RARBAPPAKR1C3AKR1C2RORC
SCHEMBL9809569 0.90 RARB (0.50) RARBAPPAKR1C3AKR1C2RORC
SCHEMBL3158592 0.88 MAOB (0.45) RARBKIF11MAOBADORA3
SCHEMBL6059779 0.88 RARB (0.42) RARBAKR1C3AKR1C2RORCRARA
SCHEMBL3163337 0.88 RARB (0.39) RARBRARARARGPSEN1MAOB
SCHEMBL3153745 0.87 RARB (0.41) RARBAPPAKR1C3AKR1C2RORC
SCHEMBL3167606 0.87 RARB (0.48) RARBRARARARGPSMB5MPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP claimed
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 RARB 4021/4885APP 1081/4885AKR1C3 2117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.